# Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood

> **NCT01497184** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 95 (actual)

## Conditions studied

- Leukemia
- Lymphoma

## Interventions

- **PROCEDURE:** HSCT
- **GENETIC:** DLI

## Key facts

- **NCT ID:** NCT01497184
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2021-03-08
- **Final completion:** 2021-03-08
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2025-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01497184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01497184, "Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT01497184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*